HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexander Zukiwski Selected Research

onapristone

1/2018Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
7/2015A single-dose PK study of onapristone including the effect of food on absorption.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexander Zukiwski Research Topics

Disease

2Neoplasms (Cancer)
01/2018 - 03/2016
2Breast Neoplasms (Breast Cancer)
01/2018 - 07/2015
2Infections
12/2017 - 01/2017
1Carcinoma (Carcinomatosis)
12/2020
1Pulmonary Embolism
12/2020
1Disease Progression
12/2020
1Endometrial Neoplasms (Endometrial Cancer)
01/2018
1Proteostasis Deficiencies
12/2017
1Prion Diseases (Transmissible Spongiform Encephalopathies)
12/2017
1Rubella (German Measles)
10/2016
1Measles
10/2016
1Mumps
10/2016
1Human Influenza (Influenza)
10/2016
1Prostatic Neoplasms (Prostate Cancer)
07/2015

Drug/Important Bio-Agent (IBA)

2onapristoneIBA
01/2018 - 07/2015
2Endoplasmic Reticulum Chaperone BiPIBA
10/2016 - 03/2016
2Proteins (Proteins, Gene)FDA Link
10/2016 - 03/2016
1Aurora Kinase AIBA
12/2020
1ENMD 2076IBA
12/2020
1RNA (Ribonucleic Acid)IBA
12/2020
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
12/2020
1Progesterone Receptors (Progesterone Receptor)IBA
01/2018
1PrionsIBA
12/2017
1Antiviral Agents (Antivirals)IBA
01/2017
1Peptide Hydrolases (Proteases)FDA Link
10/2016
1Viral ProteinsIBA
10/2016
1ThioredoxinsIBA
03/2016
1CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA
03/2016
1Phosphotransferases (Kinase)IBA
03/2016

Therapy/Procedure

1Duration of Therapy
01/2018